BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 1345 | Download: 1552
Publication Name World Journal of Immunology
Manuscript ID 4874
Country Japan
ISSN 2219-2824 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Role of IL28B genotype in older hepatitis C virus-infected patients
Manuscript Source Invited Manuscript
All Author List Tatsuo Kanda, Shingo Nakamoto, Shuang Wu and Osamu Yokosuka
Funding Agency and Grant Number
Corresponding Author Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. kandat-cib@umin.ac.jp
Key Words Hepatitis C virus; Interferon lambda 3; Interleukin-28B; Older patients; Telaprevir
Core Tip The exact mechanisms of the effects of interleukin-28B (IL28B) genotype on the treatment response in chronic hepatitis C patients are unclear. However, IL28B genotype is useful for the continued successful treatment of older patients infected with hepatitis C virus (HCV) and avoiding adverse events. Until the eventual availability of interferon-free regimens, it is important to determine IL28B genotype before treating HCV-infected individuals, especially in the screening of older patients.
Publish Date 2013-11-29 02:07
Citation Kanda T, Nakamoto S, Wu S, Yokosuka O. Role of IL28B genotype in older hepatitis C virus-infected patients. World J Immunol 2013; 3(3): 54-61
URL http://www.wjgnet.com/2219-2824/full/v3/i3/54.htm
DOI http://dx.doi.org/10.5411/wji.v3.i3.54
Full Article (PDF) WJI-3-54.pdf